| scholarly article | Q13442814 |
| P50 | author | Waqas Jehangir | Q41680217 |
| P2093 | author name string | Subir Kumar Maulik | |
| Balram Bhargava | |||
| Vishwanath Pattan | |||
| Sandeep Seth | |||
| P2860 | cites work | Pioglitazone produces rapid and persistent reduction of vascular inflammation in patients with hypertension and type 2 diabetes mellitus who are receiving angiotensin II receptor blockers | Q80015974 |
| Aspirin prevents adhesion of T lymphoblasts to vascular smooth muscle cells | Q28217990 | ||
| Risk stratification in unstable angina and non-Q wave myocardial infarction using soluble cell adhesion molecules | Q28365442 | ||
| The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation | Q29620219 | ||
| Control of vascular cell proliferation and migration by PPAR-gamma: a new approach to the macrovascular complications of diabetes | Q32050179 | ||
| Investigation of the vascular and pleiotropic effects of atorvastatin and pioglitazone in a population at high cardiovascular risk | Q33380278 | ||
| Early increase in levels of soluble inter-cellular adhesion molecule-1 (sICAM-1); potential risk factor for the acute coronary syndromes. | Q34300526 | ||
| Beneficial cardiovascular pleiotropic effects of statins | Q34327115 | ||
| Vascular effects of TZDs: new implications | Q34567958 | ||
| A novel pleiotropic effect of statins: prevention of cardiac hypertrophy by cholesterol-independent mechanisms | Q35565491 | ||
| Statins as antiinflammatory and immunomodulatory agents: a future in rheumatologic therapy? | Q36382202 | ||
| PROactive 07: pioglitazone in the treatment of type 2 diabetes: results of the PROactive study. | Q36536316 | ||
| Role of cell adhesion molecules and immune-cell migration in the initiation, onset and development of atherosclerosis | Q37080012 | ||
| ICAM-1 signaling in endothelial cells | Q37421151 | ||
| Relationship between endothelial dysfunction, carotid artery intima media thickness and circulating markers of vascular inflammation in obese hypertensive children and adolescents. | Q39824112 | ||
| Circulating soluble adhesion molecules ICAM-1 and VCAM-1 and their association with clinical outcome, troponin T and C-reactive protein in patients with acute coronary syndromes | Q40146583 | ||
| Circulating soluble adhesion molecules ICAM-1 and VCAM-1 and incident coronary heart disease: the PRIME Study | Q40564036 | ||
| Plasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men. | Q40872170 | ||
| Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: the Atherosclerosis Risk In Communities (ARIC) study | Q40873641 | ||
| Protection from procedural myocardial injury by atorvastatin is associated with lower levels of adhesion molecules after percutaneous coronary intervention: results from the ARMYDA-CAMs (Atorvastatin for Reduction of MYocardial Damage during Angiopl | Q43446003 | ||
| 15-Deoxy-D12,14-prostaglandin J2 inhibits CX3CL1/fractalkine expression in human endothelial cells | Q44198194 | ||
| Antidiabetic PPAR gamma-activator rosiglitazone reduces MMP-9 serum levels in type 2 diabetic patients with coronary artery disease | Q44316923 | ||
| Risk stratification in secondary prevention: advances in multimarker profiles, or back to basics? | Q44565606 | ||
| Reduction in serum levels of adhesion molecules, interleukin-6 and C-reactive protein following short-term low-dose atorvastatin treatment in patients with non-familial hypercholesterolemia. | Q44571805 | ||
| Statin therapy, LDL cholesterol, C-reactive protein, and coronary artery disease | Q45213515 | ||
| Impact of insulin sensitivity treatment with pioglitazone on endothelial function in non-diabetic patients with arterial hypertension. | Q45994390 | ||
| Amlodipine reduces the antimigratory effect of diclofenac in spontaneously hypertensive rats | Q46609100 | ||
| Impact of pioglitazone on coronary endothelial function in non-diabetic patients with coronary artery disease | Q46626095 | ||
| Effects of ramipril on endothelial function and the expression of proinflammatory cytokines and adhesion molecules in young normotensive subjects with successfully repaired coarctation of aorta: a randomized cross-over study | Q46750166 | ||
| Peroxisome proliferator-activated receptor-gamma activation with pioglitazone improves endothelium-dependent dilation in nondiabetic patients with major cardiovascular risk factors | Q46930716 | ||
| Correlation between inflammation and oxidative stress in normocholesterolemic coronary artery disease patients 'on' and 'off' atorvastatin for short time intervals | Q46988928 | ||
| Lack of an effect of pioglitazone or glipizide on lipoprotein-associated phospholipase A2 in type 2 diabetes. | Q53554271 | ||
| C-Reactive Protein and Cardiovascular Disease Risk: Still an Unknown Quantity? | Q57126723 | ||
| The JNC 7 hypertension guidelines | Q73923823 | ||
| Pioglitazone improves endothelial function in non-diabetic patients with coronary artery disease | Q79320030 | ||
| Anti-inflammatory effects of pioglitazone and/or simvastatin in high cardiovascular risk patients with elevated high sensitivity C-reactive protein: the PIOSTAT Study | Q79615264 | ||
| P433 | issue | 8 | |
| P921 | main subject | stable angina | Q3617336 |
| P304 | page(s) | 613-619 | |
| P577 | publication date | 2015-06-09 | |
| P1433 | published in | Journal of Clinical Medicine Research | Q26842453 |
| P1476 | title | Effect of Atorvastatin and Pioglitazone on Plasma Levels of Adhesion Molecules in Non-Diabetic Patients With Hypertension or Stable Angina or Both | |
| P478 | volume | 7 |
Search more.